Skip to search formSkip to main contentSkip to account menu

flutiform

Known as: fluticasone-formoterol 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

AndrostadienesDrug CombinationsEthanolamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting β2-Agonist Fluticasone Propionate/Formoterol Fumarate: A 36-Month Longitudinal Cohort Study in UK Primary Care
The inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) fluticasone propionate/formoterol fumarate (FP/FORM; Flutiform®) has… 
2018
2018
Patients’ ability to use a novel fluticasone propionate/formoterol breath-triggered inhaler (BTI) vs. budesonide/formoterol dry powder inhaler (DPI)
Introduction: GINA guidelines recognise the importance of correct inhaler technique and patient preference when individualising… 
2017
2017
Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.
BACKGROUND Fluticasone propionate/formoterol (FP/FORM) is a pressurized metered-dose inhaler (pMDI; Flutiform®) approved for use… 
2016
2016
Economic Evaluation of Fluticasone Propionate/Formoterol (Flutiform®) vs. Fluticasone/Salmeterol and Budesonide/Formoterol in Spain
IntroductionThe aim of this economic evaluation was to estimate the cost-effectiveness of fluticasone propionate/formoterol (FP… 
Review
2015
Review
2015
Revising old principles of inhaled treatment in new fixed combinations for asthma.
2015
2015
Plume Characteristics of Two HFA-Driven Inhaled Corticosteroid/Long-Acting Beta2-Agonist Combination Pressurized Metered-Dose Inhalers
IntroductionNew inhalers propelled by hydrofluoroalkanes (HFAs) have improved plume characteristics: higher fine particle… 
2014
2014
In vitro lung deposition of fluticasone propionate/formoterol (FP/FORM) pressurized metered dose inhaler (pMDI) with different inhalation profiles
Rationale When assessing simulated deposition of pMDIs, it is normal to use a Sinusoidal Inhalation (SI) profile, similar to… 
2014
2014
Une nouvelle association fixe de fluticasone/formotérol dans un aérosol-doseur pressurisé pour le traitement de l’asthme
2013
2013
P166 Effects of low-vs high-dose fluticasone/formoterol combination therapy on AMP challenge in asthmatic patients
Background The ICS fluticasone propionate (FP) and the LABA formoterol fumarate (FORM) have now been combined in a single aerosol… 
2011
2011
Transparency in evidence-based pediatric asthma guidelines: GRADE and the other considerations
Introduction: International evidence-based pediatric asthma guidelines are often not used in clinical practice. In step 3 of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)